Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis

Thorax

Volumn 73, Issue 4, 2018, Pages 391-392

  Gimenez, Andrea ^a   Storrer, Karin ^a   Kuranishi, Lilian ^a   Soares, Maria Raquel ^a   Ferreira, Rimarcs Gomes ^a   Pereira, Carlos A C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

hypersensitivity pneumonitis

Indexed keywords

ADULT; ALL CAUSE MORTALITY; ALLERGIC PNEUMONITIS; ARTICLE; CHRONIC FIBROTIC HYPERSENSITIVITY PNEUMONITIS; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; HUMAN; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL; AGED; COMPARATIVE STUDY; FIBROSING ALVEOLITIS; KAPLAN MEIER METHOD; LUNG LAVAGE; MIDDLE AGED; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; VITAL CAPACITY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 85045059563     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2017-210035     Document Type: Article

References (10)

1. Pereira CA, Gimenez A, Kuranishi L, et al. Chronic hypersensitivity pneumonitis. J Asthma Allergy 2016;9:171-81.
2. Vourlekis JS, Schwarz MI, Cherniack RM, et al. The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis. Am J Med 2004;116:662-8.
3. Hanak V, Golbin JM, Hartman TE, et al. High-resolution CT findings of parenchymal fibrosis correlate with prognosis in hypersensitivity pneumonitis. Chest 2008;134:133-8.
4. Ryerson CJ, Vittinghoff E, Ley B, et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 2014;145:723-8.
5. Takemura T), Akashi T, Kamiya H, Ikushima S, Ando T, Oritsu M, Sawahata M, Ogura T. pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 2012;61:1026-35.
6. Walsh SL, Sverzellati N, Devaraj A, et al. Chronic hypersensitivity pneumonitis: high resolution computed tomography patterns and pulmonary function indices as prognostic determinants. Eur Radiol 2012;22:1672-9.
7. Reichmann WM, Yu YF, Macaulay D, et al. Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis. BMC Pulm Med 2015;15:167.
8. Karimi-Shah BA, Chowdhury BA. Forced vital capacity in idiopathic pulmonary fibrosis-FDA review of pirfenidone and nintedanib. N Engl J Med 2015;372:1189-91.
9. Pereira CA, Sato T, Rodrigues SC. New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33:397-406.
10. Morisset J, Johannson KA, Vittinghoff E, et al. Use of Mycophenolate Mofetil or Azathioprine for the management of chronic hypersensitivity pneumonitis. Chest 2017;151:619-25.